A Novel Immunomodulator Delivery Platform Based on Bacterial Biomimetic Vesicles for Enhanced Antitumor Immunity-Reference-Cited by-同舟云学术

A Novel Immunomodulator Delivery Platform Based on Bacterial Biomimetic Vesicles for Enhanced Antitumor Immunity

Published:2021-09-12 Issue:43 Volume:33 Page:2103923
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Hua Liangqun¹²,Yang Zhongqian¹,Li Weiran¹,Zhang Qishu¹,Ren Zhaoling³,Ye Chao¹,Zheng Xiao¹²,Li Duo¹⁴,Long Qiong¹,Bai Hongmei¹,Sun Wenjia¹,Yang Xu¹,Zheng Peng¹,He Jinrong¹⁵,Chen Yongjun¹,Huang Weiwei¹^ORCID,Ma Yanbing¹

Affiliation:

1. Laboratory of Molecular Immunology Institute of Medical Biology Chinese Academy of Medical Sciences and Peking Union Medical College 935 Jiaoling Road Kunming 650118 China

2. School of Life Sciences Yunnan University 2 Cuihu North Road Kunming 650091 China

3. The Second Affiliated Hospital of Kunming Medical University 374 Dian Burma Avenue Kunming 650101 China

4. Department of Acute Infectious Diseases Control and Prevention Yunnan Provincial Center for Disease Control and Prevention 158 Dongsi Street Kunming 530112 China

5. Kunming Medical University 1168 Chunrong West Road Kunming 650500 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202103923

Reference76 articles.

1. CXCL17 and ICAM2 Are Associated With a Potential Anti-Tumor Immune Response in Early Intraepithelial Stages of Human Pancreatic Carcinogenesis

2. Cancer despite immunosurveillance: immunoselection and immunosubversion